PortfoliosLab logoPortfoliosLab logo
TWST vs. CRSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TWST vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Twist Bioscience Corporation (TWST) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TWST achieves a 188.62% return, which is significantly higher than CRSP's -8.49% return.


TWST

1D
0.24%
1M
-7.75%
6M
122.91%
YTD
188.62%
1Y
171.82%
3Y*
58.73%
5Y*
-5.74%
10Y*
ALL TIME*
28.65%

CRSP

1D
-0.93%
1M
-20.12%
6M
-3.94%
YTD
-8.49%
1Y
-14.44%
3Y*
-5.25%
5Y*
-16.89%
10Y*
ALL TIME*
12.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$77.21M$89.27M$90.29M
$113.24M$125.54M$135.60M

TWST vs. CRSP - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
TWST
Twist Bioscience Corporation
188.62%-31.74%26.07%54.81%-69.23%-45.23%572.81%-9.05%77.62%
CRSP
CRISPR Therapeutics AG
-8.49%33.23%-37.12%54.00%-46.36%-50.51%151.39%113.18%-10.72%

Correlation

The correlation between TWST and CRSP is 0.45, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.45

Correlation (3Y)
Balances recent behavior with more history.

0.52

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.59

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2018

0.54

The correlation between TWST and CRSP shifts across timeframes, from 0.45 (1 year) to 0.59 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TWST:

$5.70B

CRSP:

$4.63B

EPS

TWST:

-$1.33

CRSP:

-$6.15

PS Ratio

TWST:

13.65

CRSP:

1.08K

PB Ratio

TWST:

12.41

CRSP:

2.54

Total Revenue (TTM)

TWST:

$409.48M

CRSP:

$4.10M

Gross Profit (TTM)

TWST:

$213.23M

CRSP:

-$171.17M

EBITDA (TTM)

TWST:

-$58.23M

CRSP:

-$509.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TWST vs. CRSP — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TWST
TWST Risk / Return Rank: 9393
Overall Rank
TWST Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
TWST Sortino Ratio Rank: 9292
Sortino Ratio Rank
TWST Omega Ratio Rank: 8888
Omega Ratio Rank
TWST Calmar Ratio Rank: 9797
Calmar Ratio Rank
TWST Martin Ratio Rank: 9595
Martin Ratio Rank

CRSP
CRSP Risk / Return Rank: 3434
Overall Rank
CRSP Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
CRSP Sortino Ratio Rank: 3434
Sortino Ratio Rank
CRSP Omega Ratio Rank: 3434
Omega Ratio Rank
CRSP Calmar Ratio Rank: 3333
Calmar Ratio Rank
CRSP Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TWST vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Twist Bioscience Corporation (TWST) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TWSTCRSPDifference
Sharpe ratioReturn per unit of total volatility

+2.78

Sortino ratioReturn per unit of downside risk

+2.94

Omega ratioGain probability vs. loss probability

1.34

1.00

+0.33

Calmar ratioReturn relative to maximum drawdown

6.15

-0.35

+6.50

Martin ratioReturn relative to average drawdown

14.14

-0.54

+14.68

TWST vs. CRSP - Sharpe Ratio Comparison

The current TWST Sharpe Ratio is 2.53, which is higher than the CRSP Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of TWST and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TWST vs. CRSP - Drawdown Comparison

The maximum TWST drawdown since its inception was -94.48%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for TWST and CRSP.


Loading charts...

Drawdown Indicators


TWSTCRSPDifference

Max Drawdown

Largest peak-to-trough decline

-94.48%

-85.11%

-9.37%

Max Drawdown (1Y)

Largest decline over 1 year

-28.27%

-42.25%

+13.98%

Max Drawdown (3Y)

Largest decline over 3 years

-58.97%

-64.91%

+5.94%

Max Drawdown (5Y)

Largest decline over 5 years

-91.54%

-77.31%

-14.23%

Current Drawdown

Current decline from peak

-55.98%

-77.15%

+21.17%

Average Drawdown

Average peak-to-trough decline

-58.11%

-49.59%

-8.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.27%

27.26%

-14.99%

Volatility

TWST vs. CRSP - Volatility Comparison

Twist Bioscience Corporation (TWST) has a higher volatility of 19.68% compared to CRISPR Therapeutics AG (CRSP) at 14.89%. This indicates that TWST's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TWSTCRSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.68%

14.89%

+4.79%

Volatility (6M)

Calculated over the trailing 6-month period

50.21%

42.58%

+7.63%

Volatility (1Y)

Calculated over the trailing 1-year period

68.91%

58.68%

+10.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.24%

60.64%

+15.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.24%

64.15%

+14.09%

Dividends

TWST vs. CRSP - Dividend Comparison

Neither TWST nor CRSP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TWST vs. CRSP - Financials Comparison

This section allows you to compare key financial metrics between Twist Bioscience Corporation and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


TWST and CRSP have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TWST has higher volatility (19.68%) compared to CRSP (14.89%). In terms of maximum drawdown, TWST dropped -94.48% vs CRSP's -85.11%.

TWST currently has the higher Sharpe Ratio (2.53 vs -0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TWST and CRSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer